Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites

• Main Authors: Dongliang Chen (Author), Yuanfei Wang (Author), Jianmei Yang (Author), Wanyi Ou (Author), Guiru Lin (Author), Ze Zeng (Author), Xiaomin Lu (Author), Zumin Chen (Author), Lili Zou (Author), Yaling Tian (Author), Aiping Wu (Author), Shelley E. Keating (Author), Qinhe Yang (Author), Chenli Lin (Author), Yinji Liang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Purpose: The prevalence of non-alcoholic fatty liver disease (NAFLD) and its related mortality is increasing at an unprecedented rate. Traditional Chinese medicine (TCM) has been shown to offer potential for early prevention and treatment of NAFLD. The new mechanism of "Shenling Baizhu San"...